StonvexLoading…
StonvexStonvexStonvexCore line items from CMBT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $940.25M | $1.24B | $854.67M | $419.77M |
Operating Income | $1.00B | $969.69M | $294.27M | $-281.57M |
Net Income | $870.83M | $858.03M | $203.25M | $-338.78M |
EPS (Diluted) | $4.44 | $4.25 | $1.01 | $-1.68 |
Total Assets | $3.91B | $3.42B | $3.97B | $3.77B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $38.87M | $429.37M | $179.93M | $152.53M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 194.22M | 202.23M | 201.78M | 201.68M |